Serial #79293599
LIVE

Serial Number

79293599

Owner

HEALIOS K.K.

Attorney

Stacey J. Watson, Esq.

Filing Date

Jul 8, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79293599 Trademark

Serial Number: 79293599 • Registration: 6648758

Serial #79293599 is a trademark filed by HEALIOS K.K. on July 8, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

HEALIOS K.K. (16 trademarks)

1-1-2 Yuraku-cho,

Entity Type: 99

Trademark Details

Filing Date

July 8, 2020

Registration Date

February 22, 2022

Published for Opposition

December 7, 2021

Goods & Services

Adjuvants for medical purposes; cells for medical use; biological cell preparations for the treatment of diseases and disorders, namely, ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, urological, and peripheral artery related diseases and disorders, as well as type 1 and type 2 diabetes, gynecological disease and stroke; pharmaceutical preparations for the prevention or treatment of ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, urological, and peripheral artery related diseases and disorders, as well as type 1 and type 2 diabetes, gynecological disease and stroke

Medical apparatus and instruments, namely, instruments and syringes for the regeneration of stem cells for medical purposes, excluding any electrical pulsing technology instruments; Medical apparatus and instruments, namely, instruments and syringes for medical use for administration or transplanting of stem cells or cells differentiated from iPS cells, excluding any electrical pulsing technology instruments; prosthetic tissues for parietal, visceral and vascular use; Medical apparatus and instruments, namely, syringes for medical purposes for injections for administration or transplanting of stem cells or cells differentiated from iPS cells, excluding any electrical pulsing technology instruments; Medical apparatus and instruments, namely, syringes for medical purposes for injections for the regeneration of stem cells for medical purposes, excluding any electrical pulsing technology instruments; eye testing machines and apparatus; Medical apparatus and instruments, namely, instruments and syringes for treating of ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, and gynecological diseases and disorders, as well as type 1 and type 2 diabetes and stroke, and for administration or transplanting of stem cells or cells differentiated from iPS cells, excluding any electrical pulsing technology instruments; and Medical apparatus and instruments, namely, instruments and syringes for treating of ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, and gynecological diseases and disorders, as well as type 1 and type 2 diabetes and stroke, and for the regeneration of stem cells for medical purposes, excluding any electrical pulsing technology instruments

Scientific and medical research and development in the field of cells; research and development of pharmaceuticals and medical apparatus and instruments for others; research and development services relating to medicines; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
May 14, 2023 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 16, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 27, 2022 FICS
FINAL DISPOSITION PROCESSED
Jul 27, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 22, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 22, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Dec 13, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 7, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 3, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 3, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 3, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 3, 2021 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 13, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 13, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 13, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 7, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 6, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 6, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 6, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 6, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 6, 2021 COAR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 27, 2021 ADCH
REFUSAL PROCESSED BY IB
Nov 29, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 12, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 12, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 23, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 22, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 19, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 22, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 17, 2020 REPR